Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2009
08/13/2009US20090203133 Determinants of Sensitivity to Chemotherapeutic Agents
08/13/2009US20090203131 Polyamides for nucleic acid delivery
08/13/2009US20090203128 Nogo-Receptors and Methods of Use
08/13/2009US20090203127 Nematode Fatty Acid Desaturase-Like Sequences
08/13/2009US20090203125 Mig-7 as a specific anticancer target
08/13/2009US20090203124 Mage-a3 peptides presented by hla-dr1 molecules
08/13/2009US20090203123 for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy
08/13/2009US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
08/13/2009US20090203121 Nucleic acid agents for downregulating h19, and methods of using same
08/13/2009US20090203114 Novel methods and interferon deficient substrates for the propagation of viruses
08/13/2009US20090203110 COMPOSITION EXHIBITING A VON WILLEBRAND FACTOR (vWF) PROTEASE ACTIVITY COMPRISING A POLYPEPTIDE CHAIN WITH THE AMINO ACID SEQUENCE AAGGILHLELLV
08/13/2009US20090203107 nucleic acid sequence encoding a polypeptide that exhibits Alpha-L-Arabinofuranosidase activity; degrading, cleaving, or removing polysaccharides including cellulose
08/13/2009US20090203105 URA5 gene and methods for stable genetic integration in yeast
08/13/2009US20090203097 Strain for butanol production
08/13/2009US20090203095 Novel engineered microorganism producing homo-succinic acid and method for preparing succinic acid using the same
08/13/2009US20090203094 Use Of Genes For Increasing The Oil Content In Plants
08/13/2009US20090203093 Protein Targeting To Lipid Bodies
08/13/2009US20090203089 Isolated alcohol dehydrogenase enzymes and uses thereof
08/13/2009US20090203087 Expression of Granular Starch Hydrolyzing Enzymes in Trichoderma and process for producing glucose from granular starch substrates
08/13/2009US20090203081 Inducible expression vectors and methods of use thereof
08/13/2009US20090203077 Method of producing factor viii proteins by recombinant methods
08/13/2009US20090203076 Compositions and methods for increasing protein production
08/13/2009US20090203074 Bacillus Host Cell
08/13/2009US20090203073 Gene Encoding G-Protein Coupled Receptor and Gene Product Thereof
08/13/2009US20090203071 Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor
08/13/2009US20090203055 Compositions and methods for RNA interference with sialidase expression and uses thereof
08/13/2009US20090203049 Beta integrin gene and protein
08/13/2009US20090203046 Methods for identifying purkinje cells using the corl2 gene as a target
08/13/2009US20090203044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
08/13/2009US20090203042 Novel bt toxin receptors from lepidopteran insects and methods of use
08/13/2009US20090203041 Bmp4 inhibitors
08/13/2009US20090203036 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
08/13/2009US20090203035 Fluorescent proteins with increased photostability
08/13/2009US20090203029 Nucleic Acid Analysis Using Non-templated Nucleotide Addition
08/13/2009US20090203026 Methods and compositions for targeting secretory lysosomes
08/13/2009US20090203024 Secreted protein called 36p6d5 characteristic of tumors
08/13/2009US20090203009 Novel method for high-throughput integrated chemical and biochemical reactions
08/13/2009US20090203003 Inhibition of metallo-beta-lactamase
08/13/2009US20090202991 biomarkers, immunohistochemistry, non-invasive, for determining the state of a particular disease in the human body; for prognosis, prediction, screening, early diagnosis, staging, therapy selection and treatment monitoring of a marker-detectable disease such as cancer
08/13/2009US20090202988 Trap vectors and gene trapping using the same
08/13/2009US20090202979 Production of antibody formats and immunological applications of said formats
08/13/2009US20090202703 Fad-2 mutants and high oleic plants
08/13/2009US20090202675 Polypeptide
08/13/2009US20090202627 Methods and compositions for diseases associated with amyloidosis
08/13/2009US20090202623 Gene therapy for cancer using small interfering rna specific to ant2 and a method to overcome tolerance to antitumor agent
08/13/2009US20090202618 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
08/13/2009US20090202595 Anti-pdef antibodies and uses thereof
08/13/2009US20090202594 Anti-bacterial Vaccine Compositions
08/13/2009US20090202591 Leucine-based motif and clostridial neurotoxins
08/13/2009US20090202588 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences
08/13/2009US20090202587 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof
08/13/2009US20090202586 Attenuated vaccine for tularemia
08/13/2009US20090202585 Tat-based tolerogen compositions and methods for making and using same
08/13/2009US20090202584 Treatment of epstein-barr virus-associated diseases
08/13/2009US20090202577 CASB618 Polynucleotides and Polypeptides and Their Use
08/13/2009US20090202576 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
08/13/2009US20090202575 Immunostimulatory nucleic acid molecules
08/13/2009US20090202567 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
08/13/2009US20090202563 C20ORF23 as modifier of the IGFR pathway and methods of use
08/13/2009US20090202561 Novel raag10 cell surface target and a family of antibodies recognizing that target
08/13/2009US20090202556 Anti-claudin-4 antibody
08/13/2009US20090202553 Antibodies against anthrax protective antigen
08/13/2009US20090202552 Gene expressed in prostate cancer and methods of use
08/13/2009US20090202550 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
08/13/2009US20090202549 Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses
08/13/2009US20090202547 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
08/13/2009US20090202543 Gene and polypeptide relating to breast cancer
08/13/2009US20090202539 METHOD FOR TREATING CANCER USING ANTI-WNT2 MONOCLONAL ANTIBODIES AND siRNA
08/13/2009US20090202532 High Functional Bispecific Antibody
08/13/2009US20090202530 Identification of Tumor-Associated Antigens for Diagnosis and Therapy
08/13/2009US20090202528 Surface-Located Streptococcus Pneumoniae Polypeptides
08/13/2009US20090202526 Agonist anti-trkc antibodies and methods using same
08/13/2009US20090202512 Proteins for use in human and animal staphylococcus infections
08/13/2009US20090202511 Targeted protein replacement for the treatment of lysosomal storage disorders
08/13/2009US20090202506 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma
08/13/2009US20090202504 Methods for the detection and prognosis of breast tumors
08/13/2009US20090202503 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof
08/13/2009US20090202501 Chimeric NK receptor and methods for treating cancer
08/13/2009US20090202492 Adenovirus vaccine utilizing ikk as adjuvant
08/13/2009US20090202489 Adenoviruses mutated in the va genes for cancer treatment
08/13/2009US20090202488 Use Of The Foamy Virus Bet Protein For Inactivating APOBEC
08/13/2009US20090202474 Expression of orphan gpr64 in inflammatory diseases
08/13/2009US20090202472 Molecules and chimeric molecules thereof
08/13/2009US20090202471 Molecules with effects on cellular development and function
08/13/2009US20090202441 Compositions and methods to prevent cancer with cupredoxins
08/13/2009US20090202440 Model animal of dendritic cell immunoreceptor gene knockout disease
08/13/2009US20090202438 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
08/13/2009US20090202437 Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases
08/13/2009US20090202429 Methods for testing anti-thrombotic agents
08/13/2009CA2715127A1 Siva3, its preparation and use
08/13/2009CA2714972A1 Use of p27kip1 for the prevention and treatment of heart failure
08/13/2009CA2714477A1 Methods and compositions
08/13/2009CA2714413A1 Antibody capable of binding specifically to ab-oligomer, and use thereof
08/13/2009CA2714400A1 Brassica ogura restorer line r1931 with shortened raphanus fragment (srf)
08/13/2009CA2714378A1 Treatment of chronic pain with zinc finger proteins
08/13/2009CA2714271A1 Methods and compositions for plant pest control
08/13/2009CA2714151A1 Methods and devices for producing biomolecules
08/13/2009CA2714144A1 Maize leaf- and stalk-preferred promoter
08/13/2009CA2714121A1 Selection of rna-aptamers as anti-malaria agents
08/13/2009CA2714071A1 Alpha 5 - beta 1 antibodies and their uses
1 ... 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 ... 4023